Fear not - our engineers are working flat out to keep us growing.
General recruitment info is here, and our blog covers all the new developments at Showmax.
Most aging brains have these buildups, but not nearly at the level linked to early-onset Alzheimer’s.
Massachusetts-based pharmaceutical company Biogen developed the drug, aducanumab, and funded the study. Though researchers remain “cautiously optimistic” due to the small trial size, neurologist and study co-author Stephen Salloway told the magazine: “This is the best news we’ve had in 25 years of doing Alzheimer’s research.” One hundred sixty-five people with mild to moderate Alzheimer’s participated in the study, and were given a monthly intravenous dose of either aducanumab or a placebo.
Her parents sent her to Catholic schools, and her mother, a retired district judge, now jokes that she wants her money back.
Her daughter’s beat is in the vilest corners of cyberspace, in chat rooms indicating “fetish” or various subgenres of flagrant peccancy.
The only window is high on the wall, over a tall filing cabinet, and opens into a well, below ground level.